Bone regeneration using n-methyl-2-pyrrolidone as an enhancer for recombinant human bone morphogenetic protein-2 in a rabbit sinus augmentation model

Hyun Chang Lim, Daniel S. Thoma, So Ra Yoon, Jae Kook Cha, Jung Seok Lee, Ui-Won Jung

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The aim of this study was to determine whether N-methyl-2-pyrrolidone (NMP) can decrease the dose of recombinant human bone morphogenetic protein-2 (rhBMP-2) in sinus augmentation of rabbits. In each of 15 rabbits, 2 sinuses were randomly grafted using 1 of 3 treatment modalities: (i) biphasic calcium phosphate (BCP; control), (ii) rhBMP-2-coated BCP (BMP), or (iii) rhBMP-2-coated BCP soaked in NMP solution (BMP/NMP). The rabbits were sacrificed 2 weeks postoperatively. Histologic and histomorphometric analyses were performed. Bone formation in all groups was predominantly located close to the access window and the lateral walls. Newly formed bone within the total augmented area (NBTA) was greatest in BMP/NMP (1.94±0.69 mm2), followed by BMP (1.50±0.72 mm2) and BCP (1.28±0.52 mm2) (P>0.05). In the center of the augmentation (NBROI-C) and the area close to the sinus membrane (NBROI-M), BMP/NMP produced the largest area of NB (NBROI-C: 0.10±0.11 mm2; NBROI-M: 0.17±0.08 mm2); the corresponding NB values for BCP were 0.05±0.05 mm2 and 0.08±0.09 mm2, respectively (P>0.05 for all comparisons). The effect of NMP on bone regeneration was inconsistent between the specimens. Adding NMP as an adjunct to rhBMP-2-coated BCP produced inconsistent effects on bone regeneration, resulting in no significant benefit compared to controls.

Original languageEnglish
Article number4153073
JournalBioMed Research International
Volume2017
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Bone Regeneration
Bone
Rabbits
2-pyrrolidone
recombinant human bone morphogenetic protein-2
N-methylpyrrolidone
Osteogenesis
Membranes
Bone and Bones

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

@article{c19a2df66b8147d08d5832894d3492dc,
title = "Bone regeneration using n-methyl-2-pyrrolidone as an enhancer for recombinant human bone morphogenetic protein-2 in a rabbit sinus augmentation model",
abstract = "The aim of this study was to determine whether N-methyl-2-pyrrolidone (NMP) can decrease the dose of recombinant human bone morphogenetic protein-2 (rhBMP-2) in sinus augmentation of rabbits. In each of 15 rabbits, 2 sinuses were randomly grafted using 1 of 3 treatment modalities: (i) biphasic calcium phosphate (BCP; control), (ii) rhBMP-2-coated BCP (BMP), or (iii) rhBMP-2-coated BCP soaked in NMP solution (BMP/NMP). The rabbits were sacrificed 2 weeks postoperatively. Histologic and histomorphometric analyses were performed. Bone formation in all groups was predominantly located close to the access window and the lateral walls. Newly formed bone within the total augmented area (NBTA) was greatest in BMP/NMP (1.94±0.69 mm2), followed by BMP (1.50±0.72 mm2) and BCP (1.28±0.52 mm2) (P>0.05). In the center of the augmentation (NBROI-C) and the area close to the sinus membrane (NBROI-M), BMP/NMP produced the largest area of NB (NBROI-C: 0.10±0.11 mm2; NBROI-M: 0.17±0.08 mm2); the corresponding NB values for BCP were 0.05±0.05 mm2 and 0.08±0.09 mm2, respectively (P>0.05 for all comparisons). The effect of NMP on bone regeneration was inconsistent between the specimens. Adding NMP as an adjunct to rhBMP-2-coated BCP produced inconsistent effects on bone regeneration, resulting in no significant benefit compared to controls.",
author = "Lim, {Hyun Chang} and Thoma, {Daniel S.} and Yoon, {So Ra} and Cha, {Jae Kook} and Lee, {Jung Seok} and Ui-Won Jung",
year = "2017",
month = "1",
day = "1",
doi = "10.1155/2017/4153073",
language = "English",
volume = "2017",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

Bone regeneration using n-methyl-2-pyrrolidone as an enhancer for recombinant human bone morphogenetic protein-2 in a rabbit sinus augmentation model. / Lim, Hyun Chang; Thoma, Daniel S.; Yoon, So Ra; Cha, Jae Kook; Lee, Jung Seok; Jung, Ui-Won.

In: BioMed Research International, Vol. 2017, 4153073, 01.01.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bone regeneration using n-methyl-2-pyrrolidone as an enhancer for recombinant human bone morphogenetic protein-2 in a rabbit sinus augmentation model

AU - Lim, Hyun Chang

AU - Thoma, Daniel S.

AU - Yoon, So Ra

AU - Cha, Jae Kook

AU - Lee, Jung Seok

AU - Jung, Ui-Won

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The aim of this study was to determine whether N-methyl-2-pyrrolidone (NMP) can decrease the dose of recombinant human bone morphogenetic protein-2 (rhBMP-2) in sinus augmentation of rabbits. In each of 15 rabbits, 2 sinuses were randomly grafted using 1 of 3 treatment modalities: (i) biphasic calcium phosphate (BCP; control), (ii) rhBMP-2-coated BCP (BMP), or (iii) rhBMP-2-coated BCP soaked in NMP solution (BMP/NMP). The rabbits were sacrificed 2 weeks postoperatively. Histologic and histomorphometric analyses were performed. Bone formation in all groups was predominantly located close to the access window and the lateral walls. Newly formed bone within the total augmented area (NBTA) was greatest in BMP/NMP (1.94±0.69 mm2), followed by BMP (1.50±0.72 mm2) and BCP (1.28±0.52 mm2) (P>0.05). In the center of the augmentation (NBROI-C) and the area close to the sinus membrane (NBROI-M), BMP/NMP produced the largest area of NB (NBROI-C: 0.10±0.11 mm2; NBROI-M: 0.17±0.08 mm2); the corresponding NB values for BCP were 0.05±0.05 mm2 and 0.08±0.09 mm2, respectively (P>0.05 for all comparisons). The effect of NMP on bone regeneration was inconsistent between the specimens. Adding NMP as an adjunct to rhBMP-2-coated BCP produced inconsistent effects on bone regeneration, resulting in no significant benefit compared to controls.

AB - The aim of this study was to determine whether N-methyl-2-pyrrolidone (NMP) can decrease the dose of recombinant human bone morphogenetic protein-2 (rhBMP-2) in sinus augmentation of rabbits. In each of 15 rabbits, 2 sinuses were randomly grafted using 1 of 3 treatment modalities: (i) biphasic calcium phosphate (BCP; control), (ii) rhBMP-2-coated BCP (BMP), or (iii) rhBMP-2-coated BCP soaked in NMP solution (BMP/NMP). The rabbits were sacrificed 2 weeks postoperatively. Histologic and histomorphometric analyses were performed. Bone formation in all groups was predominantly located close to the access window and the lateral walls. Newly formed bone within the total augmented area (NBTA) was greatest in BMP/NMP (1.94±0.69 mm2), followed by BMP (1.50±0.72 mm2) and BCP (1.28±0.52 mm2) (P>0.05). In the center of the augmentation (NBROI-C) and the area close to the sinus membrane (NBROI-M), BMP/NMP produced the largest area of NB (NBROI-C: 0.10±0.11 mm2; NBROI-M: 0.17±0.08 mm2); the corresponding NB values for BCP were 0.05±0.05 mm2 and 0.08±0.09 mm2, respectively (P>0.05 for all comparisons). The effect of NMP on bone regeneration was inconsistent between the specimens. Adding NMP as an adjunct to rhBMP-2-coated BCP produced inconsistent effects on bone regeneration, resulting in no significant benefit compared to controls.

UR - http://www.scopus.com/inward/record.url?scp=85021692036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021692036&partnerID=8YFLogxK

U2 - 10.1155/2017/4153073

DO - 10.1155/2017/4153073

M3 - Article

VL - 2017

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 4153073

ER -